Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Thank you for standing by for the Cigna Group's fourth quarter 2024 results review. At this time, all callers are in a listen ...

New York Blood Center Enterprises revealed that it has been hit by a ransomware attack, disrupting activities and blood ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

The attack is frequently cited by the UK government as among the worst the country has faced in recent times, with thousands ...

Nurses in Oregon and elsewhere have become increasingly anxious since a tech company’s announcement it had developed a $9-an-hour AI program that could take over work normally done by nurses paid ten ...

Broadcom Inc. (AVGO), and Motorola Solutions (MSI). This theme touches a select group of stocks in almost every industry. We have built two investment products that leverage this theme: a UIT with our ...

For two years in a row, shares of our healthcare juggernaut UnitedHealth Group have lagged significantly. So, why are we ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Ladies, and gentlemen, thank you for standing by for the Cigna Group fourth-quarter 2024 results review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.